Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;18(2):308-11.
doi: 10.3201/eid1802.111466.

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11

Aaron D Storms  1 , Larisa V Gubareva, Su Su, John T Wheeling, Margaret Okomo-Adhiambo, Chao-Yang Pan, Erik Reisdorf, Kirsten St George, Robert Myers, Jason T Wotton, Sara Robinson, Brandon Leader, Martha Thompson, Marjorie Shannon, Alexander Klimov, Alicia M Fry; US Antiviral Resistance Surveillance Working Group
Collaborators, Affiliations

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11

Aaron D Storms et al. Emerg Infect Dis. 2012 Feb.

Abstract

During October 2010-July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 2009-10 influenza season. Of resistant viruses from 2010-11 and 2009-10, 26% and 89%, respectively, were from persons exposed to oseltamivir before specimen collection. Findings suggest limited community transmission of oseltamivir-resistant virus.

PubMed Disclaimer

Figures

Figure
Figure
Geographic distribution of oseltamivir-resistant pandemic (H1N1) 2009 viruses in the United States, October 1, 2010–July 31, 2011. Numerators are number of oseltamivir-resistant viruses identified by state public health laboratories; denominators are number of pandemic (H1N1) 2009–positive specimens submitted by each state for susceptibility testing. Gray shading indicates states that had >1 infection with oseltamivir-resistant virus.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. Update: influenza activity—United States, 2009–10 season. MMWR Morb Mortal Wkly Rep. 2010;59:901–8. - PubMed
    1. Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, et al. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis. 2011;17:255–7. - PMC - PubMed
    1. Ives JAL, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, et al. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 2002;55:307–17. 10.1016/S0166-3542(02)00053-0 - DOI - PubMed
    1. Nguyen HT, Sheu TG, Mishin VP, Klimov AI, Gubareva LV. Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob Agents Chemother. 2010;54:3671–7. 10.1128/AAC.00581-10 - DOI - PMC - PubMed
    1. Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, et al. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother. 2010;54:1102–10. 10.1128/AAC.01417-09 - DOI - PMC - PubMed

LinkOut - more resources